BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3100428)

  • 1. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
    Unertl K; Lenhart FP; Ruckdeschel G
    Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
    Unertl K; Ruckdeschel G; Forst H; Lenhart FP
    Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
    Krech T; Naumann P
    Immun Infekt; 1986 Nov; 14(6):224-6. PubMed ID: 3100426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia treated with imipenem/cilastatin.
    Salata RA; Gebhart RL; Palmer DL; Wade BH; Scheld WM; Groschel DH; Wenzel RP; Mandell GL; Duma RJ
    Am J Med; 1985 Jun; 78(6A):104-9. PubMed ID: 3859208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 3():S513-7. PubMed ID: 3931199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pedersen SS; Pressler T; Høiby N; Bentzon MW; Koch C
    J Antimicrob Chemother; 1985 Nov; 16(5):629-35. PubMed ID: 3935639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of imipenem/cilastatin in severely burned and infected patients.
    Culbertson GR; McManus AT; Conarro PA; McManus WF; Mason AD; Pruitt BA
    Surg Gynecol Obstet; 1987 Jul; 165(1):25-8. PubMed ID: 3109046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin for the treatment of infections in hospitalized children.
    Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
    Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem/cilastatin in the treatment of severe hospital infections.
    Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
    Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
    Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].
    Mayer M; Brand J; Schlenkhoff D; Opferkuch W
    Infection; 1986; 14 Suppl 2():S160-3. PubMed ID: 3079549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical experience with imipenem-cilistatin.
    Ellis-Pegler RB; Downey D; Bremner DA
    N Z Med J; 1985 Mar; 98(775):188-91. PubMed ID: 3856762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.